메뉴 건너뛰기




Volumn 15, Issue 3, 2011, Pages 673-680

Synthetic route discovery and introductory optimization of a novel process to idebenone

Author keywords

[No Author keywords available]

Indexed keywords

BENZOQUINONES; ENVIRONMENTALLY BENIGN; HECK CROSS-COUPLING REACTION; METHYLBENZENES; NOVEL PROCESS; OLEFIN REDUCTION; SYNTHETIC ROUTES; TOTAL SYNTHESIS;

EID: 79957440170     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op200051v     Document Type: Article
Times cited : (14)

References (65)
  • 21
    • 79957503026 scopus 로고    scopus 로고
    • Phase III Study of Idebenone in Duchenne Muscular Dystrophy. ClinicalTrials.gov identifier: NCT01027884.
    • Phase III Study of Idebenone in Duchenne Muscular Dystrophy. ClinicalTrials.gov identifier: NCT01027884.
  • 22
    • 79957439813 scopus 로고    scopus 로고
    • Study to Assess Efficacy, Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy. ClinicalTrials.gov identifier NCT00747487.
    • Study to Assess Efficacy, Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy. ClinicalTrials.gov identifier NCT00747487.
  • 23
    • 79957463835 scopus 로고    scopus 로고
    • Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes. ClinicalTrials.gov identifier: NCT00887562.
    • Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes. ClinicalTrials.gov identifier: NCT00887562.
  • 24
    • 79957451561 scopus 로고    scopus 로고
    • Double Blind Placebo-Controlled phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis. ClinicalTrials.gov identifier: NCT00950248.
    • Double Blind Placebo-Controlled phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis. ClinicalTrials.gov identifier: NCT00950248.
  • 34
    • 0010357352 scopus 로고
    • See for example:;, and references cited therein
    • See for example: Wehrli, P. A.; Pigott, F. Org. Synth. 1972, 52, 83 and references cited therein
    • (1972) Org. Synth. , vol.52 , pp. 83
    • Wehrli, P.A.1    Pigott, F.2
  • 40
    • 79957466029 scopus 로고    scopus 로고
    • Chem. Abstr. 2008, 151, 248827.
    • (2008) Chem. Abstr. , vol.151 , pp. 248827
  • 42
    • 79957507085 scopus 로고    scopus 로고
    • Chem. Abstr. 2007, 148, 561618.
    • (2007) Chem. Abstr. , vol.148 , pp. 561618
  • 44
    • 79957467395 scopus 로고    scopus 로고
    • Chem. Abstr. 2009, 150, 144143.
    • (2009) Chem. Abstr. , vol.150 , pp. 144143
  • 45
    • 84876274233 scopus 로고    scopus 로고
    • See for example:, Ed.; Wiley: Chichester, U.K.
    • See for example: Oestreich, M., Ed. The Mizoroki-Heck Reaction; Wiley: Chichester, U.K., 2009; pp 1 - 608.
    • (2009) The Mizoroki-Heck Reaction , pp. 1-608
    • Oestreich, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.